Yield10 Bioscience (YTEN) Peer Comparison

$0.02

$0.00 (0.00%)

As on 21-Feb-2025 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

11.2

Div. Yield

0 %

Edit

	Yield10 Bioscience (YTEN)	Singular Genomics Systems Inc (OMIC)
Market cap ($ Mln)	0	51
Revenue ($ Mln)	1	3
Net Profit ($ Mln)	-12.70	-86.32
Net Margin (%)	-1,568.15	-3,237.88
RoE (%)	--	-61.67
Price to Earnings	--	--
Price-To-Book	11.23	0.41

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Yield10 Bioscience (YTEN)	Singular Genomics Systems Inc (OMIC)
Operating Revenue	0.81	2.67
Cost of Revenue	0.15	5.74
Gross Profit	-0.23	-0.56
Operating Expenses	13.40	89.93
Operating Profit (EBIT)	-12.59	-93.00
Other Income	0.00	0.00
Profit before Tax	-12.70	-86.32
Provision for Tax	-0.20	2.22
Profit after Tax (Net Income)	-12.70	-86.32
Minority Interest	0.00	0.00
Consolidated Profit	0.00	0.00

Liabilities ($ Mln)

	Yield10 Bioscience (YTEN)	Singular Genomics Systems Inc (OMIC)
Shareholder's Funds	-6.24	123.25
Minority Interest	0.00	0.00
Non-Current Liabilities	1.54	45.69
Current Liabilities	7.67	17.61
Total Liabilities	3.91	265.47

Assets ($ Mln)

	Yield10 Bioscience (YTEN)	Singular Genomics Systems Inc (OMIC)
Non-Current Assets	1.76	56.74
Current Assets	1.20	129.81
Total Assets	3.91	265.47
Total Debt*	2.79	50.49
Net Current Assets	-6.47	112.20

Cashflow ($ Mln)

	Yield10 Bioscience (YTEN)	Singular Genomics Systems Inc (OMIC)
Cash From Operating Activities	-10.07	-73.65
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	6.87	0.70
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Yield10 Bioscience (YTEN)	Singular Genomics Systems Inc (OMIC)
ROCE (%)	-371.98	-33.07
ROE (%)	-1,508.09	-61.67
ROA (%)	-133.87	-34.25
EBIT Margin (%)	-1,153.83	-3,195.01
Net Margin (%)	-1,568.15	-3,237.88
Cash Profit Margin (%)	-0.01	0.00

Growth Ratios

	Yield10 Bioscience (YTEN)	Singular Genomics Systems Inc (OMIC)
Revenue Growth (%)	213.95	2.74
EBIT Growth (%)	34.31	8.74
Net Profit Growth (%)	10.78	3.83
EPS Growth (%)	--	-245.68
Book Value Growth (%)	--	-39.60

Valuation Ratios

	Yield10 Bioscience (YTEN)	Singular Genomics Systems Inc (OMIC)
Price / Earnings	--	-0.01
Price / Book Value	--	0.01
Dividend Yield (%)	--	--
EV/EBITDA	-0.15	1.13
Market Cap ($ Cr)	--	--

Solvency Ratios

	Yield10 Bioscience (YTEN)	Singular Genomics Systems Inc (OMIC)
Debt to Equity	0.00	0.04
Short term debt to equity ratio	-0.27	0.04
Current Ratio	0.16	7.37
Quick Ratio	0.16	6.67
Interest Coverage	-704.67	-74.52

Operating Efficiency Ratios

	Yield10 Bioscience (YTEN)	Singular Genomics Systems Inc (OMIC)
Debtors to sales (%)	0.00	37.92
Asset Turnover	0.09	0.01
Receivable days	182.63	225.60
Inventory Days	0.00	1,673.74
Payable days	825.59	299.34
Cash Conversion Cycle	-642.96	1,600.00

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly